ENTA Market Cap History
Below is a table of the ENTA market cap history going back to 3/21/2013:

Date ENTA Market Cap
3/21/2013289.25M
5/10/2013354.59M
8/9/2013316.50M
12/16/2013653.09M
2/10/2014702.95M
5/9/2014643.26M
8/8/2014694.99M
12/1/2014827.51M
1/30/2015811.48M
4/30/2015640.01M
7/31/2015947.86M
11/30/2015592.04M
1/31/2016486.38M
8/1/2016424.50M
12/1/2016594.78M
12/27/2016634.99M
2/1/2017624.55M
5/1/2017613.15M
8/1/2017734.98M
12/1/2017946.93M
2/1/20181.65B
5/1/20181.84B
8/1/20181.94B
11/1/20181.54B
1/31/20191.54B
4/28/20191.76B
7/30/20191.52B
7/26/20192.55B

Also see: ENTA Shares Outstanding History
and ENTA YTD Return
ENTA Historical Market Cap:
+40.85% CAGR
ENTA Historical Market Cap: +40.85% CAGR

Mouse over chart for data details
3/21/2013 ...7/26/2019
Enanta Pharmaceuticals is a biotechnology company that creates small molecule drugs primarily for the treatment of viral infections and liver diseases. Co.'s wholly owned research and development programs are in virology, namely respiratory syncytial virus and hepatitis B virus, and in liver disease (non-virology), namely non-alcoholic steatohepatitis and primary biliary cholangitis. Through its Collaborative Development and License Agreement with AbbVie Inc (AbbVie), Co. has developed and licensed to AbbVie two protease inhibitor compounds that have been clinically tested, manufactured, and commercialized by AbbVie for the treatment of hepatitis C virus. We show 28 historical shares outstanding datapoints in our ENTA shares outstanding history coverage, used to compute ENTA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ENTA market cap history over the course of time is important for investors interested in comparing ENTA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ENTA versus a peer is one thing; comparing ENTA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ENTA can fluctuate over the course of history. With this page we aim to empower investors researching ENTA by allowing them to research the ENTA market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ENTA:
ENTA SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Enanta Pharmaceuticals (ENTA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ENZ Market Cap History
EPZM Market Cap History
ESPR Market Cap History
ESRX Market Cap History
EVFM Market Cap History
EVHC Market Cap History
EVOK Market Cap History
EW Market Cap History
EXAS Market Cap History
EXEL Market Cap History
More Healthcare companies »

 

ENTA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.